Translate AMICOR contents if you like

Showing posts with label Guidelines. Show all posts
Showing posts with label Guidelines. Show all posts

Monday, June 03, 2013

Guideline for Guidelines WHO

David Sinclair1, Rachel Isba1, Tamara Kredo2, Babalwa Zani2, Helen Smith3, Paul Garner1
1 Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom,
2 South African Cochrane Centre, Cape Town, South Africa,
3 Department of International Public Health, Liverpool School of Tropical Medicine, LiverpoolUnited Kingdom

Artigo sugerido pela AMICOR Maria  InĂªs Reinert Azambuja

PloS ONE -  May 31, 2013 - Volume 8 - Issue 5 - e63715
Available online at: http://bit.ly/13g8zrG

“……Research in 2007 showed that World Health Organization (WHO) recommendations were largely based on expert opinion, rarely used systematic evidence-based methods, and did not follow the organization's own “Guidelines for Guidelines”. In response, the WHO established a “Guidelines Review Committee” (GRC) to implement and oversee internationally recognized standards. We examined the impact of these changes on WHO guideline documents and explored senior staff's perceptions of the new procedures.

Methods and Findings
We used the AGREE II guideline appraisal tool to appraise ten GRC-approved guidelines from nine WHO departments, and ten pre-GRC guidelines matched by department and topic. We interviewed 20 senior staff across 16 departments and analyzed the transcripts using the framework approach. Average AGREE II scores for GRC-approved guidelines were higher across all six AGREE domains compared with pre-GRC guidelines.
The biggest changes were noted for “Rigour of Development” (up 37.6%, from 30.7% to 68.3%) and “Editorial Independence” (up 52.7%, from 20.9% to 73.6%).

Four main themes emerged from the interviews:

(1) high standards were widely recognized as essential for WHO credibility, particularly with regard to conflicts of interest;
(2) views were mixed on whether WHO needed a single quality assurance mechanism, with some departments purposefully bypassing the procedures;
(3) staff expressed some uncertainties in applying the GRADE approach, with departmental staff concentrating on technicalities
      while the GRC remained concerned the underlying principles were not fully institutionalized;
(4) the capacity to implement the new standards varied widely, with many departments looking to an overstretched GRC for technical support.


Conclusions

Since 2007, WHO guideline development methods have become more systematic and transparent. However, some departments are bypassing the procedures, and as yet neither the GRC, nor the quality assurance standards they have set, are fully embedded within the organization….”


Also available Online: http://bit.ly/ZHwjXi

Appendix S1. Draft Interview Guide.

Appendix S2. Full AGREE II appraisal scores for pre- and post-GRC guidelines.

Appendix S3. AGREE II appraisal scores for three recent guidelines that did not seek GRC approval.

Table S1.Theme 1: High standards essential for credibility.

Table S2. Theme 2: Mixed views on the need for a single quality assurance process.

Table S3.Theme 3: Uncertainties about applying the GRADE methods.

Table S4. Theme 4: Variable capacity to implement the new standard.


KMC/2013/HSS
Twitter
 http://twitter.com/eqpaho 

Monday, November 19, 2012

AHA Guidelines IHD


  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and  Management of Patients With Stable Ischemic Heart Disease: A Report of
  the American College of Cardiology Foundation/American Heart Association
  Task Force on Practice Guidelines, and the American College of
  Physicians, American Association for Thoracic Surgery, Preventive
  Cardiovascular Nurses Association, Society for Cardiovascular Angiography
  and Interventions, and Society of Thoracic Surgeons
  Stephan D. Fihn, Julius M. Gardin, Jonathan Abrams, Kathleen Berra, James
  C. Blankenship, Apostolos P. Dallas, Pamela S. Douglas, JoAnne M. Foody,
  Thomas C. Gerber, Alan L. Hinderliter, Spencer B. King III, Paul D.
  Kligfield, Harlan M. Krumholz, Raymond Y.K. Kwong, Michael J. Lim, Jane
  A. Linderbaum, Michael J. Mack, Mark A. Munger, Richard L. Prager, Joseph
  F. Sabik, Leslee J. Shaw, Joanna D. Sikkema, Craig R. Smith, Jr, Sidney
  C. Smith, Jr, John A. Spertus, and Sankey V. Williams
  Circulation. Originally published November 19, 2012. doi:
  10.1161/CIR.0b013e318277d6a0
  http://circ.ahajournals.org/content/early/2012/11/19/CIR.0b013e318277d6a0.full.pdf?papetoc


  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and
  Management of Patients With Stable Ischemic Heart Disease: Executive
  Summary: A Report of the American College of Cardiology
  Foundation/American Heart Association Task Force on Practice Guidelines,
  and the American College of Physicians, American Association for Thoracic
  Surgery, Preventive Cardiovascular Nurses Association, Society for
  Cardiovascular Angiography and Interventions, and Society of Thoracic
  Surgeons
  Stephan D. Fihn, Julius M. Gardin, Jonathan Abrams, Kathleen Berra, James
  C. Blankenship, Apostolos P. Dallas, Pamela S. Douglas, JoAnne M. Foody,
  Thomas C. Gerber, Alan L. Hinderliter, Spencer B. King III, Paul D.
  Kligfield, Harlan M. Krumholz, Raymond Y.K. Kwong, Michael J. Lim, Jane
  A. Linderbaum, Michael J. Mack, Mark A. Munger, Richard L. Prager, Joseph
  F. Sabik, Leslee J. Shaw, Joanna D. Sikkema, Craig R. Smith, Jr, Sidney
  C. Smith, Jr, John A. Spertus, and Sankey V. Williams
  Circulation. Originally published November 19, 2012. doi:
  10.1161/CIR.0b013e3182776f83
  http://circ.ahajournals.org/content/early/2012/11/19/CIR.0b013e3182776f83.full.pdf?papetoc

Thursday, January 19, 2012

Sexual Activity and Cardiovascular Disease

AHA Scientific Statement
-----------------------------------------------------------------

Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Glenn N. Levine, Elaine E. Steinke, Faisal G. Bakaeen, Biykem Bozkurt, Melvin D. Cheitlin, Jamie Beth Conti, Elyse Foster, Tiny Jaarsma, Robert A. Kloner, Richard A. Lange, Stacy Tessler Lindau, Barry J. Maron, Debra K. Moser, E. Magnus Ohman, Allen D. Seftel, William J. Stewart  on behalf of the American Heart Association Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on Cardiovascular Surgery and Anesthesia,
and Council on Quality of Care and Outcomes Research Circulation published 19 January 2012, 10.1161/CIR.0b013e3182447787


Sexual activity is an important component of patient and partner quality of life for men and women with cardiovascular disease (CVD), including many elderly patients.
Decreased sexual activity and function are common in patients with CVD and are often interrelated to anxiety and depression.
The intent of this American Heart Association Scientific Statement is to synthesize and summarize data
relevant to sexual activity and heart disease in order to provide recommendations and foster physician and other
healthcare professional communication with patients about sexual activity. Recommendations in this document are based on published studies, the Princeton Consensus Panel, the 36th Bethesda Conference, European Society of Cardiology recommendations on physical activity and sports participation for patients with CVD, practice guidelines from the American College of Cardiology/American Heart Association and other organizations, and the multidisciplinary expertise of the writing group. The classification of recommendations in this document are based on established ACCF/AHA criteria (Table)
http://circ.ahajournals.org/cgi/reprint/CIR.0b013e3182447787v1?papetoc

Monday, September 28, 2009

Heroes of the Environment 2009

Heroes of the Environment 2009

ILLUSTRATION FOR TIME BY CECELIA WONG






From saving wild mountain rivers in China to measuring the Arctic's icy expanse, from protecting the lush forests of Africa to conducting a feisty online debate, our green heroes are informed by this simple notion: We can all make a difference/.../

Thursday, November 13, 2008

Classification of Care Metrics: Performance Measures and Quality Metrics

ACC/AHA Classification of Care Metrics: Performance Measures and Quality
Metrics: A Report of the American College of Cardiology/American Heart
Association Task Force on Performance Measures
Robert O. Bonow, Frederick A. Masoudi, John S. Rumsfeld, Elizabeth DeLong,
N. A. Mark Estes, III, David C. Goff, Jr, Kathleen Grady, Lee A. Green, Ann
R. Loth, Eric D. Peterson, Ileana L. Pina, Martha J. Radford, and David M.
Shahian

Circulation published 12 November 2008, 10.1161/CIRCULATIONAHA.108.191107
http://circ.ahajournals.org/cgi/content/abstract/CIRCULATIONAHA.108.191107v1?papetoc

Abstract—The American College of Cardiology (ACC) and the American Heart Association (AHA) have provided leadership in enhancing the quality of cardiovascular care, including the development of clinical performance measures and clinical registries that permit the evaluation of quality of care and stimulate quality improvement. Compliance with ACC/AHA performance measures and metrics encourages the provision of the strongest evidence-based quality of care, including therapies that are life-extending or life-enhancing. Among quality metrics, only a subset should be considered performance measures—that is, those measures specifically suitable for public reporting, external comparisons, and possibly pay-for-performance programs, in addition to quality improvement. These performance measures have been developed using ACC/AHA methodology, often in collaboration with other organizations, and include the process of public comment and peer review. Quality metrics are those measures that have been developed to support self assessment and quality improvement at the provider, hospital, and/or health care system level.These metrics represent valuable tools to aid clinicians and hospitals in improving quality of care and enhancing patient outcomes, but may not meet all specifications of formal performance measures. These quality metrics may also be considered "candidate" measures that with further research or field testing would meet the criteria for formal performance measures in the future. This measure classification is intended to aid providers, hospitals, health systems, and payers in identifying those measures that the ACC and AHA formally endorse as performance measures, while at the same time promoting the broader range of clinical metrics that are useful for quality improvement efforts.

Tuesday, October 02, 2007

Prevention of Cardiovascular Diseases: WHO-Guidelines

This and other recent publication on CVD prevention are available through the following address:
http://www.who.int/cardiovascular_diseases/resources/publications/en/index.html
Prevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk

Overview
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event. People with established cardiovascular disease are at very high risk of recurrent events and are not the subject of these guidelines. They have been addressed in previous WHO guidelines. The WHO/ISH risk prediction charts that accompany these guidelines allow treatment to be targeted according to simple predictions of absolute cardiovascular risk.
Recommendations are made for management of major cardiovascular risk factors through changes in lifestyle and prophylactic drug therapies. The guidelines provide a framework for the development of national guidance on prevention of cardiovascular disease that takes into account the particular political, economic, social and medical circumstances.
(This publication was released on 24 August 2007)
Download DocumentPrevention of cardiovascular disease: guideline for assessment and management of cardiovascular risk [pdf 2.52Mb]